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Recent studies have implicated that a GTP-binding protein (G-protein) is involved in the coupling of both 
CCK-8 and muscarinic cholinergic receptors to phosphoinositidase C (PIC) in the human embryonic pitui- 
tary cell line, Flow 9000. Pretreatment of these ceils with cholera toxin, but not pertussis toxin, inhibited 
the stimulation of [aH]inositol phosphate production by CCK-8 and acetylcholine. These inhibitory effects 
of cholera toxin could not be reproduced by treating the cells with the B-subunit of cholera toxin or cAMP- 
generating agents uch as forskolin. These data suggest the presence of a novel Gc protein which is responsi- 
ble for receptor-PIC coupling in Flow 9000 cells. 
Cholera toxin; G-protein; Inositol phosphate; Cholecystokinin; Acetylcholine; (Flow 9000 cell) 
1. INTRODUCTION 
It is now generally accepted that receptor- 
mediated hydrolysis of phosphatidylinositol 
4,5-bisphosphate (PIP2) by phosphoinositidase C 
(PIC) is a common transmembrane signalling 
mechanism for calcium-mobilizing hormones and 
neurotransmitters [1,2]. Recent evidence also in- 
dicates that a GTP-binding protein (G-protein) is 
involved in the regulation of receptor-PIC cou- 
pling [3-6]. In the human embryonic pituitary cell 
line Flow 9000, we have ~-eported the presence of 
functional cholecystokinin (CCK-8) and musca- 
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rinic cholinergic receptors. Activation of these 
receptors leads to the breakdown of PIP2. In 
saponin-permeabilized Flow 9000 cells, the non- 
hydrolysable analogue of GTP, GTP[S], 
significantly potentiated the PIP2 responses in- 
itiated by CCK-8 and muscarinic agonists im- 
plicating the mediation of a G-protein [7]. 
Reports have accumulated in the past 2 years 
that suggested at least two G-proteins participate 
in receptor-PIC coupling. In neutrophils [8], 
HL-60 cells [9] and human polymorphonuclear 
leukocytes [10], a pertussis toxin substrate G- 
protein has been implicated in coupling the chemo- 
tactic peptide receptor to P1C. Similar findings 
were also reported in compound 48/80-stimulated 
mast cells [11] and thrombin stimulation of PIPz 
hydrolysis in hamster fibroblastic CCL39 cells 
[12]. In contrast, a G-protein (GP0 which is neither 
a substrate for pertussis toxin nor cholera toxin 
regulates PIP2 responses activated by muscarinic 
receptors in astrocytoma cells [13] and in cardiac 
myocytes [14]; TRH receptors in GH3 cells [15]; 
angiotensin, vasopressin and ~l-adrenergic recep- 
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tors in rat liver membranes [16]. Recently, 
evidence has accrued that a cholera toxin-sensitive 
G-protein is involved in receptor-PIC regulation 
[17,18]. Pike and Eakes [17] showed that cholera 
toxin was able to abolish the ability of EGF to 
stimulate an increase in P IP contents in A431 cells. 
In the T-cell cell line Jurkat, Imboden et al. [18] 
reported that CT inhibits T-cell antigen receptor- 
mediated stimulation in both inositol trisphos- 
phate and cytosolic calcium contents. 
Here, we have investigated the effects of cholera 
toxin on CCK-8 and muscarinic stimulation of in- 
ositol phosphate accumulation in the human em- 
bryonic pituitary cell line Flow 9000. 
2. MATERIALS AND METHODS 
The human embryonic pituitary cell line Flow 
9000 was purchased from Flow Laboratories 
(Hefts, England). Cells were cultured in Ham's  
F10 medium in the presence of sera [6]. Procedures 
for [3H]inositol prelabelling and agonist stimula- 
tion of the cells as well as the extraction and 
separation of [3H]inositol phosphates by anion- 
exchange chromatography were as described [19]. 
Cholera toxin was added only after the cells had 
been labelled with [~H]inositol to isotopic equilib- 
rium (48 h) for either 5 or 24 h. Cyclic AMP 
(cAMP) production induced by cholera toxin treat- 
ment with or without the phosphodiesterase in-
hibitor, 3-isobutyl- 1-methylxanthine (IBMX, 
0.5 mM), was determined by radioimmunoassay 
using the ~25I-cAMP-RIA kit purchased from New 
England Nuclear. Labelled or pretreated cells were 
usually washed thoroughly with physiological buf- 
fer (Krebs bicarbonate buffer supplemented with 
glucose) before addition of drugs. CCK-8 (sul- 
phated) was obtained from Bachem. GTP[S] and 
forskolin were purchased from Calbiochem. 
Cholera toxin and its A- and B-subunits as well as 
pertussis toxin were obtained from List Biologicals 
(Campbell, CA). 
3. RESULTS 
Initial experiments established that cholera toxin 
used in the present study was biologically active as 
shown by its ability to stimulate cAMP production 
in intact Flow 9000 cells (table 1). The phosphodi- 
Table 1 
Effects of cholera toxin treatment on cAMP accumula- 
tion in Flow 9000 cells 
cAMP (pmol/106 cells) 
- IBMX + IBMX 
Control 12.1 + 0.3 47.4 + 2.5 
Cholera toxin 45.9 + 2.3 774.9 + 29.6 
Flow 9000 cells "were incubated with cholera toxin 
(50/zg/ml) for 5 h and then 0.5 mM IBMX was added 
to one set of control and cholera toxin-treated incuba- 
tions for another 30 min. Reaction was terminated by 
ice-cold trichloroacetic acid (6°7o) followed by ether ex- 
traction and iyophilization to remove the acid. Radioim- 
munoassay was used to determine the cAMP content. 
Data are means _+ SE of three experiments performed in
triplicate 
esterase inhibitor IBMX (0.5 mM) greatly ampli- 
fied cAMP formation elicited by cholera toxin 
treatment (50/~g/ml, 5 h). These results indicate 
that at the concentration used here, cholera toxin 
is able to stimulate cAMP accumulation presum- 
ably through ADP-ribosylating the G:protein of 
the adenylate cyclase pathway. It is also worth 
pointing out that cholera toxin pretreatment (5 or 
24 h) had no effect on the morphology (at light- 
microscopic level) and the protein content of the 
cells. 
However, pretreatment of the Flow 9000 cells 
with 50/zg/ml cholera toxin for just 5 h 
significantly inhibited accumulation of total [3H]- 
inositol phosphate ([3H]InsP) induced by CCK-8 
and acetylcholine but had no effect on basal levels 
(table 2). This inhibition of cholera toxin on 
agonist-mediated PIPE breakdown was dose- 
dependent and the ICso value of cholera toxin on 
CCK-8 stimulation of [3H]InsP production was 
2.8 _+ 0.9/zg/ml. It is significant hat even after 24 
h incubation, the maximal inhibition of cholera 
toxin on agonist-induced PIPE turnover was only 
65°0. 
Pertussis toxin did not affect CCK-8 and 
muscarinic agonist stimulation of [3H]InsP in these 
cells (table 3). However, at a similar concentration, 
pertussis toxin (50/~g/ml, 24 h) significantly block- 
ed muscarinic inhibition of prostaglandin E2 
(PGE2) stimulation of adenylate cyclase activity in 
the same cell line (not shown). In addition, per- 
tussis toxin did not alter GTP[S]-induced [3H]- 
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Table 2 
Effects of cholera toxin on agonist-induced [3H]inositol 
phosphate accumulation i Flow 9000 cells 
[3H]InsP (dpm/assay) 
Control cells CT-treated cells 
Control 1113 _ 28 1005 + 48 
CCK-8 (1 nM) 4159 + 50 2018 + 29 a 
Acetylcholine (30/zM) 5254 + 65 2978 _ 38 a 
a P<0.05 vs agonist stimulation in control cells 
[3H]Inositol-prelabeiled Flow 9000 cells were treated 
with cholera toxin (CT) at 50/zg/ml for 5 h. After 
thorough washings, cells were stimulated with agonists 
for 30 min and total [3Hlinositol phosphates ([3HllnsP) 
were extracted as described in section 2. Data are means 
___ SE of 3 independent experiments 
InsP format ion in saponin-permeabi l ized Flow 
9000 cells (table 3). 
As mentioned above, at cholera toxin concentra- 
tions that inhibited agonist-mediated PIP2 hydro- 
lysis, there was a concomitant  increase in 
accumulat ion of  cAMP in Flow 9000 cells. Ac- 
cordingly, we have tested the ability of  the cAMP-  
generating agents, noradrenal ine and forskolin, to 
modi fy  agonist- induced [3H]InsP production.  Us- 
ing a concentrat ion of  these agents which 
stimulated cAMP format ion maximally, neither of  
Table 3 
Effects of pertussis toxin (PT) pretreatment on [3H]InsP 
formation in Flow 9000 cells 
[3H]InsP (dpm/assay) 
Control PT-treated 
Intact cells 
Control 1125 _+ 90 1015 _+ 98 
CCK-8 (1 nM) 5880 _+ 605 5775 + 512 
ACh (30/~M) 5525 +_ 220 5254 +_ 120 
Permeabilized cells 
Control 1072_+ 90 1094_+ 75 
GTP[S] (100/zM) 2130 ___ 150 2075 __. 98 
[3H]Inositol-prelabelled Flow 9000 cells were prein- 
cubated with pertussis toxin (50/zg/ml) for 24 h. Cells 
were washed thoroughly and were then challenged with 
either CCK-8 (1 nM) or ACh (30/zM) for 30 min. Total 
[3H]InsP were extracted and quantified as described in 
section 2. Results are means + SE of four separate x- 
periments performed in duplicate 
Table 4 
Effects of cholera toxin and various agents on agonist- 
induced [3H]InsP formation in Flow 9000 cells 
Pretreatment [3H]InsP (dpm/assay) 
Control CCK-8 Acetylcholine 
(1 nM) (33/zM) 
Control 1037 _+ 38 4298 + 99 5269 + 76 
Cholera toxin 970 + 99 2011 + 23 a 2998 + 60 a 
(50/zg/ml) 
A-Subunit 1002 + 34 4400 + 45 5055 _+ 79 
(2.5/zg/ml) 
B-Subunit 1009 + 59 4459 + 89 5301 _+ 78 
(20/zg/ml) 
Noradrenaline 999 _+ 67 4502 +_ 101 5405 _+ 56 
(10/zM) 
Forskolin 1012 + 56 4499_+ 77 5098 +_ 40 
(33/zM) 
a P<0.05 vs agonist stimulation in control cells 
[3H]Inositol-prelabelled Flow 9000 cells were pretreated 
with various agents for 24 h. Procedures for agonist 
stimulation (30 min) and [3H]inositol phosphate xtrac- 
tion were as described in section 2. Data are means + SE 
of 4 separate xperiments 
these agents showed any effect on CCK-8 or acetyl- 
choline st imulation of  PIP2 hydrolysis (table 4). 
Table 4a lso  shows that neither the A- nor B-sub- 
unit of  cholera toxin affects receptor-mediated 
P IC activation. 
Table 5 
Effects of cholera toxin on phosphoinositide hydrolysis 
in saponin-permeabilized Flow 9000 cells 
[3H]Insp (dpm/assay) 
Control cells CT-treated cells 
Control 1069+ 80 1001 + 56 
GTP[S] (100/zM) 2233 + 54 2166 + 98 
CCK-8 (1/zM) 1234_+ 99 1188 + 43 
GTP[S] + CCK-8 4116+ 105 2608+ 150 a 
a P<0.05 vs agonist stimulation in control cells 
[3H]Inositol-labelled Flow 9000 cells were treated with 
cholera toxin (CT, 50/zg/ml) for 24 h. CT-treated cells 
were incubated with saponin (50/zg/ml) for 15 min. 
After thorough washings, CT-pretreated saponin- 
permeabilized cells were then subjected to agonist 
stimulation for 30 min and [3H]inositol phosphates were 
extracted. Results are means _+ SE of 3 separate x- 
periments 
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To elucidate the site of action of cholera toxin 
on receptor-PIC coupling, we have investigated the 
effect of cholera toxin on GTP[S] stimulation of 
PIP2 turnover as well as the potentiation of 
CCK-8-activated [3H]InsP formation by GTP[S] in 
permeabilized Flow 9000 cells. Table 5 shows that 
cholera toxin (50/zg/ml, 24 h) did not affect 
GTP[S]-stimulated [3H]InsP accumulation but 
significantly reduced the GTP[S]-potentiated 
CCK-8 response. These results suggest that the site 
of action of cholera toxin on the G~ protein is 
neither the GTP- nor PIC-binding site. Prelimina- 
ry results showed that both the maximal binding 
capacity (Bmax) and the apparent dissociation con- 
stant (Kd) of saturation binding of [3H]QNB and 
t25I-CCK-8 in intact Flow 9000 cells were not 
significantly altered by cholera toxin pretreatment 
(not shown) indicating that the primary effect of 
cholera toxin is not at the receptor level. 
4. DISCUSSION 
Previous reports have indicated that there are at 
least two classes of G-proteins involved in 
receptor-PIC Coupling. One is pertussis toxin- 
sensitive and therefore could be Go, Gi or a Go/Gi- 
like protein and is predominantly present in bone 
marrow-derived cells such as neutrophils. The 
other is not toxin-sensitive (Gp~) and is present in 
a great variety of tissues. Our studies suggest hat 
a novel G-protein, which we tentatively named G~ 
(c - cholera) regulates agonist-induced PIP2 hydro- 
lysis in Flow 9000 ceils. This Gc protein is pertussis 
toxin-insensitive. The mechanism of the inhibitory 
action of cholera toxin on receptor-PIC coupling is 
at present not clear. We are tempted to suggest that 
ADP-ribosylation of Gc is essential but ex- 
periments using [32p]NAD have yet to be per- 
formed to show that cholera toxin ADP- 
ribosylates a substrate protein in these cells. 
In WRK-1 mammary tumour ceils, vasopressin- 
activated PIP2 hydrolysis is mediated via a G- 
protein [20]. Pretreatment of WRK-1 cells with 
cholera toxin, but not with pertussis toxin, produc- 
ed a dose-dependent inhibition of vasopressin- 
stimulated inositol phosphate formation (Kirk, C. 
and Michell, R., personal communication). This 
finding further supports the role of a cholera 
toxin-sensitive G-protein in receptor-activated 
PIP2 metabolism. 
One intriguing finding was that cholera toxin 
treatment did not affect GTP[S]-stimulated PIP2 
hydrolysis in permeabilized cells (table 5). Thus, 
the site of ADP-ribosylation appears to be distal 
from both GTP- and PIC-binding sites. In con- 
trast, the potentiating effect of GTP[S] on CCK-8 
stimulation of [3H]InsP production in permeabiliz- 
ed cells was abolished by cholera toxin (table 5). 
These results suggest hat ADP-ribosylation of Gc 
by cholera toxin has in some way impaired the 
coupling between the receptor and Go. Since 
cholera toxin does not completely block the PIP2 
response, it is unlikely that complete uncoupling 
between receptor and PIC occurs. Lotersztajn et 
al. [21] have observed that cholera toxin treatment 
blocked glucagon-mediated inhibition of (Ca 2+- 
MgZ+)-ATPase in liver plasma membranes, this 
being consistent with a possible role of cholera 
toxin-sensitive substrate in regulating transmem- 
brane processes. 
In conclusion, we propose that a novel G- 
protein (G~) mediates receptor-PIC coupling in 
Flow 9000 cells. The wider implications of this 
observation require further study as does the exact 
mechanism of action of cholera toxin on the cou- 
pling process. 
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